Igg4-related Disease
📧 Sign up to get email alerts when something new happens for Igg4-related Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Zanubrutinib in Patients With IgG4-Related Disease [Phase 2]
Phase 2 trial update for zanubrutinib in IgG4-related disease; the study is completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases [EARLY_Phase 1]
An early Phase 1 clinical trial evaluating the safety and efficacy of a targeted BCMA in vivo lentiviral vector injection for recurrent or r…
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: Open Label Two-Arm Study to Evaluate Rilzabrutinib in IgG4-Related Disease Participants [Phase 2]
This open-label Phase 2 trial evaluating rilzabrutinib in immunoglobulin G4-related disease has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease [Phase 3]
Phase 3 clinical trial update evaluating the efficacy and safety of inebilizumab in IgG4-related disease, with results posted and the study …
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD) [Phase 2]
A Phase 2 trial of elotuzumab for IgG4-related disease was terminated; results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Diagnostic and Prognostic Biomarkers for IgG4-related Disease.
This clinical trial update reports on diagnostic and prognostic biomarkers for IgG4-related disease. The study aims to improve diagnosis and…
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: Safety and Efficacy of Abatacept in IgG4-Related Disease [Phase 2]
Phase 2 trial assessing safety and efficacy of abatacept in IgG4-related disease has completed with posted results in 2021.
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: Belimumab Treatment for IgG4-related Disease [Phase 4]
Clinical trial update for belimumab in IgG4-related disease (Phase 4) with unknown status.
-
CLINICAL_TRIALS trial_result · 2018-12-07Clinical Trial Update: Study to Evaluate the Effect of XmAb®5871 on Disease Activity in Patients With IgG4-Related Disease (RD) [Phase 2]
Phase 2 study evaluating XmAb5871 for IgG4-related disease has completed, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Rituximab in IgG4-RD: A Phase 1-2 Trial [Phase 1, Phase 2]
Phase 1/2 trial evaluating rituximab for IgG4-related disease has completed enrollment and posted results. The study examined retroperitonea…